ESG Data

Data related to ESG (Environment, Social, Governance)
Scope of Report: PeptiDream (PD), PDRadiopharma (PDR)

Data（Environment）
Independent Verification Statement
Data（Society）
Data（Governance）

You can see the table by scrolling horizontally.

Environment

	Scope of Report	FY2021	*FY2022^1**	FY2023	FY2024	FY2025	Remark
CO₂ Emissions
Scope1	PD	0 t-CO₂	0 t-CO₂	0.06 t-CO₂	0t-CO₂	0t-CO₂
	PDR	－	0 t-CO₂	3,156 t-CO₂	3,271t-CO₂	3,272t-CO₂
Scope2	Market base
	PD	1,327 t-CO₂	0 t-CO₂	0 t-CO₂	0t-CO₂	0t-CO₂
	PDR	－	6,385 t-CO₂	7,343 t-CO₂	6,898t-CO2	1,897t-CO₂
	Location base
	PD	－	－	1,595 t-CO₂	1,690t-CO2	1781t-CO₂
	PDR	－	－	8,121 t-CO₂	8,000t-CO2	7,922t-CO₂
Scope3
Category1	PD	－	－	11,316 t-CO₂	65,506t-CO₂	62,648t-CO₂
	PDR	－	－	59,567 t-CO₂	65,506t-CO₂	62,648t-CO₂
Category2	PD	－	－	4,720 t-CO₂	7,408t-CO₂	9,700t-CO₂
	PDR	－	－	4,720 t-CO₂	7,408t-CO₂	9,700t-CO₂
Category３	PD	227 t-CO₂	0 t-CO₂	248 t-CO₂	3,589t-CO₂	1,028t-CO₂
	PDR	－	－	1,901 t-CO₂	3,589t-CO₂	1,028t-CO₂
Category4	PD	－	－	192 t-CO₂	23,006t-CO₂	5,677t-CO₂
	PDR	－	－	18,270 t-CO₂	23,006t-CO₂	5,677t-CO₂
Category5	PD	－	－	212 t-CO₂	296t-CO₂	323t-CO₂
	PDR	－	－	107 t-CO₂	296t-CO₂	323t-CO₂
Category6	PD	－	－	28 t-CO₂	95t-CO₂	98t-CO₂
	PDR	－	－	66 t-CO₂	95t-CO₂	98t-CO₂
Category7	PD	41 t-CO₂	46t-CO₂	48 t-CO₂	227t-CO₂	231t-CO₂
	PDR	－	－	172 t-CO₂	227t-CO₂	231t-CO₂
Category11	PD	ー	ー	ー	38t-CO₂	0.05t-CO₂
	PDR	ー	ー	ー	38t-CO₂	0.05t-CO₂
Category12	PD	ー	ー	ー	18t-CO₂	6t-CO₂
	PDR	ー	ー	ー	18t-CO₂	6t-CO₂
Category14	PD	ー	ー	ー	0t-CO₂	ー
	PDR	ー	ー	ー	0t-CO₂	ー
Category15	PD	ー	ー	ー	277t-CO₂	582t-CO₂
	PDR	ー	ー	ー	277t-CO₂	582t-CO₂
CO₂ Emissions per Employee(Scope1,2)	PD	7.72 t-CO₂	0 t-CO₂	0 t-CO₂	0t-CO₂	0t-CO₂
	PDR	－	20 t-CO₂	21 t-CO₂	22t-CO₂	11t-CO₂
No. of Employees	PD	172	196	206	217	228
	PDR	－	414	450	464	476
Energy Consumption	PD Group	3,325,735kWh	17,747,020kWh	22,183,649kWh	22,856,540kWh	22,969,157kWh
of which, renewable electricty purchase	PD Group	ー	3,373,907kWh	3,642,317kWh	6,905,273kWh	18,645,930kWh	*Renewable electricity represents 30% of all energy consumption in 2025.
	PD	3,325,735kWh	3,373,907kWh	3,642,317kWh	3,994,619kWh	4,210,377kWh
of which, renewable electricty purchase	PD	ー	3,373,907kWh	3,642,317kWh*	3,994,619kWh*	4,210,377kWh	*Renewable electricity represents 100% of all energy consumption in 2025.
	PDR	ー	14,373,113kWh	18,541,332kWh	18,911,921kWh	18,758,780kWh
of which, renewable electricty purchase	PDR	ー	ー	ー	2,910,654kWh*	14,435,553kWh	*Renewable electricity represents 15% of all energy consumption in 2025.
Water Comsumption	PD	6,180㎥	5,896㎥	5,354㎥	5,516㎥	5,791㎥
	PDR	－	53,430㎥	65,743㎥	70,123㎥	70,195㎥
Water Emissions	PD	6,180㎥	5,896㎥	5,354㎥	5,516㎥	5,791㎥
	PDR	－	18,117㎥	24,068㎥	25,927㎥	25,454㎥
of which, processed in wastewater treatment facilities	PD	740.3㎥	599.6㎥	523.0㎥	547.2㎥	593.7㎥
	PDR	－	－	－	ー	ー
Pollutant^*2 Concentration（annual average）
Biochemical Oxygen Demand（BOD）	PD	34.1㎎/L	27.0㎎/L	27.3㎎/L	26.3㎎/L	31㎎/L
	PDR (Chiba Factory)	－	1.1㎎/L	1.1㎎/L	1.0㎎/L	1.0㎎/L
	PDR (Kawasaki PET Lab)	－	5.8㎎/L	7.8㎎/L	5.5㎎/L	5.1㎎/L
	PDR (Ibaraki PET Lab)	－	9.1㎎/L	less than 5.0㎎/L	Less than5.0㎎/L	5.2㎎/L
Suspended Solids（SS）	PD	27.5㎎/L	16.5㎎/L	18.58㎎/L	13.8㎎/L	19mg/L
	PDR (Chiba Factory)	－	less than 1㎎/L	less than 1㎎/L	Less than 1㎎/L	1㎎/L未満
	PDR (Kawasaki PET Lab)	－	less than10㎎/L	15.3㎎/L	13.4㎎/L	11.3㎎/L
	PDR (Ibaraki PET Lab)	－	less than10㎎/L	10.3㎎/L	10.3㎎/L	10.3㎎/L
Pollution load^*2（annual）
Biochemical Oxygen Demand（BOD）in Water	PD	32.4kg	28.1kg	24.8kg	25.5kg	19.5kg
	PDR (Chiba Factory)	－	19.0kg	24.9kg	25.0kg	24.2kg
	PDR (Kawasaki PET Lab)	－	2.3kg	5.1kg	3.7kg	3.6kg
	PDR (Ibaraki PET Lab)	－	4.2kg	3.9kg	3.6kg	3.3kg
Suspended Solids（SS）in Water	PD	29.8kg	13.6kg	11.1kg	10.9kg	20.7kg
	PDR (Chiba Factory)	－	17.3kg	22.7kg	24.5kg	24.2kg
	PDR (Kawasaki PET Lab)	－	4.0kg	10.0kg	10.2kg	8.0kg
	PDR (Ibaraki PET Lab)	－	4.7kg	8.1kg	7.5kg	6.3kg
Waste Emissions^*2	PD	119.4 tons	118.5 tons	122.4 tons	123.4 tonnes	125.7トン
	PDR	－	139.0 tons	138.5 tons	130.1 tonnes	139.3トン
of which, operational (Industrial) waste^*3	PD	109.5 tons	112.4 tons	106.8 tons	106.5 tonnes	108.8トン
	PDR	－	61.1 tons	50.8 tons	51.2 tonnes	51.7トン
of which, general waste (office)	PD	9.9 tons	6.1 tons	8.9 tons	9.5 tonnes	9.7トン
	PDR	－	30.9 tons	47.6 tons	46.1 tonnes	48.6トン
Amount of recycled	PD	6.8 tons	7.0 tons	6.7 tons	7.4 tonnes	6.4トン
	PDR	－	47.0 tons	40.1 tons	32.8 tonnes	39.0トン
No. of administrative penalties and litigations related to the environment	PD	0	0	0	0	0件
	PDR	－	0	0	0	0件

*1 Since PDRadiopharma was integrated in March 2022, the fiscal year ending December 2022 consists of 9 months from April 1 to December 31.

*2 Due to a change in definition in FY2023, the figures for FY2022 have been retroactively adjusted.

*3 Excludes PDRadiopharma's radioactive waste from radionuclides

Related Links

Social

	Scope of Report	FY2021	*FY2022^1**	FY2023	FY2024	FY2025
<Employee Data>
No. of employees^*2	PD	172	196	206	217	228
	PDR	－	414	450	464	476
No. of employees involved in R&D^*3	PD	156	172	184	195	202
	PDR	－	36	44	43	48
Ratio of employees involved in R&D^*3	PD	90.7%	87.8%	89.3%	89.9%	88.6%
	PDR	－	10.2%	9.8%	9.3%	10.1%
of which, Female	PD	61	77	81	77	79
	PDR	－	82	85	90	98
Ratio of female employees	PD	35.5%	39.3%	39.3%	35.5%	34.6%
	PDR	－	19.8%	18.9%	19.4%	20.6%
of which, non-Japanese	PD	2	3	3	4	5
	PDR	－	0	0	1	2
Ratio of non-Japanese employees	PD	1.2%	1.5%	1.5%	1.8%	2.2%
	PDR	－	0.0%	0.0%	0.2%	0.4%
No. of full-time employees	PD	142	155	153	157	169
	PDR	－	352	395	404	411
of which, Female	PD	40	45	45	41	43
	PDR	－	73	78	81	88
Ratio of female employees	PD	28.2%	29.0%	29.4%	26.1%	25.4%
	PDR	－	20.7%	19.7%	20.0%	21.4%
No. of managerial employees^*4	PD	38	43	50	61	65
	PDR	－	218	214	216	206
of which, Female	PD	7	8	8	11	11
	PDR	－	34	35	37	37
Ratio of female in managerial positions	PD	18.4%	18.6%	16.0%	18.0%	16.9%
	PDR	－	15.6%	16.4%	17.1%	18.0%
No. of senior managerial employees	PD	24	29	29	30	31
	PDR	－	114	115	112	107
of which, Female	PD	6	7	7	7	9
	PDR	－	10	10	12	12
Ratio of female in senior managerial positions	PD	25.0%	24.1%	24.1%	23.3%	29.0%
	PDR	－	8.8%	8.7%	10.7%	11.2%
Average age	PD	37.7	38.7	39.2	39.7	40.2
	PDR	－	45.2	43.9	43.7	43.6
of which, Male	PD	37.8	39.0	39.5	40.0	40.5
	PDR	－	45.5	43.9	43.5	43.6
of which, Female	PD	37.4	38.0	38.6	38.9	39.2
	PDR	－	44.2	44	44.2	43.6
Average service years	PD	3.7	4.2	4.9	5.3	5.5
	PDR	－	17.7	16	15.7	151
of which, Male	PD	3.4	4.0	4.7	5.2	5.4
	PDR	－	18.1	16	15.6	15.3
of which, Female	PD	4.3	4.7	5.4	5.6	5.7
	PDR	－	16.2	15.7	16.1	14.5
No. of hires (of which, Female)	PD	27 (3)	24(8)	15(5)	17(4)	28(7)
	PDR	－	17(1)	64(9)	33(7)	42
No. of new graduate (of which, Female)	PD	6 (0)	1 (0)	0	3(0)	2(0)
	PDR	－	2 (0)	12(2)	12(3)	17(6)
Ratio of mid-careers	PD	78%	96%	100%	82%	93%
	PDR	－	88%	81%	63.64%	51%
No. of retirees (of which, Female)	PD	14 (8)	14(4)	16(7)	14(7)	14(4)
	PDR	－	29 (4)	24(5)	17(2)	30
Turnover rate	PD	9.1%	8.2%	10.6%	9.3%	8.5%
	PDR	－	7.1%	5.9%	3.7%	6.4%
Turnover rate of hired new graduates after three years	PD	0.0%	20.0%	0.0%	16.7%	0.0%
	PDR	－	0.0%	0.0%	0.0%	2.4%
Average annual salary（thousand yen）*^5**	PD	8,826	9,662	9,592	11,692	9,519
	PDR	－	5,664	7,365	6,717	7,518
Ratio of average salaries of men to women	PD	－	84.7%	86.0%	89.3%	81.1%
	PDR	－	77.0%	81.0%	83.0%	87.8%
No. of disabled employees	PD	4	5	5	5	5
	PDR	－	8	10	12	11
Ratio of disabled employees	PD	2.8%	3.2%	3.3%	3.2%	3.1%
	PDR	－	1.9%	2.2%	2.6%	2.3%
Ratio of female employees who took maternity/childcare leave	PD	100%	100%	100%	100%	100%
	PDR	－	100%	100%	100%	100%
Ratio of male employees who took childcare leave	PD	50.0%	75.0%	50.0％	66.7%	80.0%
	PDR	－	42.9%	44.4%	36.3%	50.0%
Return rate of female employees after maternity/childcare leave	PD	66.7%	100%	100%	67%	100%
	PDR	－	100%	100%	100%	100%
Return rate of male employees after childcare leave	PD	100%	100%	100%	100%	100%
	PDR	－	100%	100%	100%	100%
No. of employees who took nursing care leave	PD	0	0	0	0	0
	PDR	－	0	0	0	0
Usage of annual paid leave	PD	68.5%	76.5%	83.9%	86.5%	87.7%
	PDR	－	68.8%	74.8%	71.1%	67.8%
Usage of summer paid leave	PD	96.5%	99.0%	99.5%	98.6%	97.2%
Ratio of employees who underwent health checkup	PD	97.2%	95.2%	96.5%	96.5%	95.4%
	PDR	－	99.8%	99.5%	99.0%	97.3%
Ratio of employees who participated Stress Check Program mandated by MHLW	PD	88.2%	95.4%	98.6%	96.6%	95.0%
	PDR	－	100%	100%	100%	100%
Ratio of employees on leave due to mental disorders	PD	2.3%	1.0%	1.3%	1.4%	1.8%
	PDR	－	0.0%	0.9%	0.4%	0.8%
<Diverse Core Human Resources Data>*^4**
Ratio of doctorate (Ph.D.) holders	PD	55.2%	51.2%	54.0%	45.0%	42.4%
Female manager ratio	PD	18.4%	18.6%	16.0%	18.3%	16.7%
Ratio of foreign employees or employees with overseas work experience	PD	31.5%	32.6%	32.0%	31.7%	34.8%
Ratio of employees (in 20s/30s)	PD	15.8%	16.3%	24.0%	20.0%	18.2%
<Other Society-related Data>
No. of occupational accidents	PD	1	0	0	1	1
	PDR	－	1	1	0	1
Fatalities	PD	0	0	0	0	0
	PDR	－	0	0	0	0
LTIFR (Lost Time Injury Frequency Rate)	PD	3.7%	0.0%	0.0%	3.5%	3.1
	PDR	－	1.3%	1.2%	0.0%	1.1%
Severity rate	PD	0.07%	0.0%	0.0%	0.03%	0
	PDR	－	0.0%	2.0%	0.0%	0.1%
OIFR (Occupational Illness Frequency Rate)	PD	0.0%	0.0%	0.0%	0.0%	0
	PDR	－	0.0%	0.0%	0.0%	0.0%
No. of administrative action and violation of laws and regulatory compliance	PD	0	0	0	0	1
	PDR	－	0	0	0	0
Political contributions（yen）	PD	0	0	0	0	0
	PDR	－	0	0	0	0
No. of whistle-blowing system hotline complaints received	PD	2	2	1	1	2
	PDR	－	0	0	0	0
No. of regulators inspections^*6	PD	－	－	－	－	－
	PDR	－	8	1	4	2
No. of warning letters, etc.^*7	PD	－	－	－	－	－
	PDR	－	0	0	0	0
Social contribution spending^*8（thousand yen）	PD	9,376	10,112	9,611	11,722	10,073
	PDR	－	114,127	146,979	63,768	54,692
Largest Contributions & Expenditures^*9	PD	454	400	500	520	520
	PDR	－	150,443	146,119	62,119	52,593
Employee volunteer hours and activity expenses^*10	PD	8,921	9,712	9,611	11,722	9,553
	PDR	－	127	860	1,649	2,099

*1 Since PDRadiopharma was integrated in March 2022, the fiscal year ending December 2022 consists of 9 months from April 1 to December 31.

*2 PeptiDream：The number of full-time, contract and temporary employees. PDRadiopharma：The number of full-time, contract employees.

*3 PDRadiopharma：The number and ratio of full-time employees.

*4 The number of managerial employees includes senior managers and senior-ranking specialists.

*5 PDRadiopharma：Calculated based on total annual salary for the 9 month from April 1 to December 31, 2022.

*6 PDRadiopharma：Number of inspections and investigations conducted by PMDA and overseas regulators.

*7 Warning letters issued by the FDA or administrative guidance/improvement orders, etc.

*8 PDRadiopharma：Due to a change in definition in FY2023, the figures for FY2022 have been retroactively adjusted.

*9 Due to a change in definition in FY2024, the figures for FY2024 have been retroactively adjusted.

*10 Volunteer engagements, etc. converted into monetary equivalents.

	Scope of Report	FY2021	FY2022	FY2023	FY2024	FY2025
Board of Directors Total	PD	7	7	7	7	6
Female	PD	1	1	1	1	2
Board of Directors (Excluding Auditing Committee Members)	PD	3	3	3	3	2
Internal Directors	PD	3	3	3	3	2
External Directors	PD	0	0	0	0	0
Board of Directors (Auditing Committee Members)	PD	4	4	4	4	4
Independent External Directors	PD	4	4	4	4	4
Ratio of Independent External Directors	PD	57.1%	57.1%	57.1%	57.1%	66.7%
Ratio of Female Directors	PD	14.3%	14.3%	14.3%	14.3%	33.3%
Ratio of Foreign Directors	PD	14.3%	14.3%	14.3%	14.3%	16.7%
Average Age of Directors	PD	55	56	57	58	57
Meeting Frequency of Board of Directors	PD	23	19	21	21	21
Meeting Attendance Ratio	PD	100%	98.5%	100%	100%	99%
Meeting Frequency of Auditing Committee	PD	14	15	14	13	18
Meeting Attendance Ratio	PD	100%	100%	100%	100%	100%
Meeting Frequency of Nomination and Compensation Committee	PD	5	4	7	8	8
Nomination and Compensation Committee Members	PD	4	4	5	5	5
Internal Directors	PD	2	2	2	2	1
Independent External Directors	PD	2	2	3	3	4
Meeting Attendance Ratio	PD	100%	93.3%	100%	100%	100%
Remuneration of Board of Directors (in thousand yen)
Board of Directors (Excluding Auditing Committee Members)	PD	301,000	540,000	485,748	690,750	265,362
Fixed Remuneration	PD	251,500	270,000	279,450	309,150	265,362
Performance-Based Remuneration	PD	49,500	270,000	206,297	381,599	ー
Board of Directors (Auditing Committee Members)	PD	20,865	22,620	23,468	24,644	27,933

Income tax by region (FY2024)

	Names of entities	Primary activities	Revenue	Profit(Loss) before tax	Income tax accrued	Income tax paid	Number of employees
Japan	PD	Drug Discovery and Development Business Segment	18,521,234	△5,312,129	12,055	8,074,244	645
Japan	PDR	Radiopharmaceutical Business Segment	18,521,234	△5,312,129	12,055	8,074,244	645
Total			18,521,234	△5,312,129	12,055	8,074,244	645

※ Thousands of Yen